What one share of Niki BioSolutions holds
Aptorum now focuses all of its efforts on R&D; it no longer provides any clinical services. As of December 31, 2025 and the date hereof, it only operates in one segment.
Niki BioSolutions’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2025-12-31; the balance sheet is as of 2025-12-31.
| Profit | −$0.19 |
|---|---|
| Cash and investments | $0.47 |
| Book value | $3.14 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2018 | — | −$5.31 | $2.02 | −$5.62 | — | $11.86 |
| 2019 | — | −$6.44 | $0.29 | −$4.90 | — | $5.64 |
| 2020 | — | $2.00 | $0.05 | −$5.10 | — | $13.44 |
| 2021 | $0.44 | −$7.15 | $0.04 | −$4.22 | — | $6.74 |
| 2022 | $0.36 | −$2.75 | $0.05 | −$3.50 | — | $4.40 |
| 2023 | $0.10 | −$0.62 | $0.00 | −$1.71 | — | $5.50 |
| 2024 | — | −$0.78 | — | — | — | $3.88 |
| 2025 | — | −$0.19 | — | — | — | $3.14 |
Common questions about Niki BioSolutions
How much does one share of Niki BioSolutions earn?
Over its latest fiscal year, Niki BioSolutions lost $0.19 for each share.
Does Niki BioSolutions pay a dividend?
Niki BioSolutions didn’t pay a dividend over its latest fiscal year, according to its SEC filings.
What is Niki BioSolutions’s book value per share?
Niki BioSolutions’s book value is $3.14 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of December 31, 2025.
How much cash and debt does each share of Niki BioSolutions have?
Each share of Niki BioSolutions has $0.47 of cash and investments, as of December 31, 2025.
Has Niki BioSolutions bought back shares?
Niki BioSolutions’s share count rose about 163% from 2018 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.